A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
| dc.contributor.author | Hutchinson, Peter J | |
| dc.contributor.author | Edlmann, Ellie | |
| dc.contributor.author | Hanrahan, John G | |
| dc.contributor.author | Bulters, Diederik | |
| dc.contributor.author | Zolnourian, Ardalan | |
| dc.contributor.author | Holton, Patrick | |
| dc.contributor.author | Suttner, Nigel | |
| dc.contributor.author | Agyemang, Kevin | |
| dc.contributor.author | Thomson, Simon | |
| dc.contributor.author | Anderson, Ian A | |
| dc.contributor.author | Al-Tamimi, Yahia | |
| dc.contributor.author | Henderson, Duncan | |
| dc.contributor.author | Whitfield, Peter | |
| dc.contributor.author | Gherle, Monica | |
| dc.contributor.author | Brennan, Paul M | |
| dc.contributor.author | Allison, Annabel | |
| dc.contributor.author | Thelin, Eric P | |
| dc.contributor.author | Tarantino, Silvia | |
| dc.contributor.author | Pantaleo, Beatrice | |
| dc.contributor.author | Caldwell, Karen | |
| dc.contributor.author | Davis-Wilkie, Carol | |
| dc.contributor.author | Mee, Harry | |
| dc.contributor.author | Warburton, Elizabeth A | |
| dc.contributor.author | Barton, Garry | |
| dc.contributor.author | Chari, Aswin | |
| dc.contributor.author | Marcus, Hani J | |
| dc.contributor.author | Pyne, Sarah | |
| dc.contributor.author | King, Andrew T | |
| dc.contributor.author | Belli, Antonio | |
| dc.contributor.author | Myint, Phyo K | |
| dc.contributor.author | Wilkinson, Ian | |
| dc.contributor.author | Santarius, Thomas | |
| dc.contributor.author | Turner, Carole | |
| dc.contributor.author | Bond, Simon | |
| dc.contributor.author | Kolias, Angelos G | |
| dc.contributor.author | British Neurosurgical Trainee Research Collaborative and Dex-CSDH Trial Collaborators | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Cardiovascular and Diabetes Centre | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2024-03-22T15:50:01Z | |
| dc.date.available | 2024-03-22T15:50:01Z | |
| dc.date.issued | 2024-03-01 | |
| dc.description | Funding This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 13/15/02) and is published in full in Health Technology Assessment; Vol. 28, No. 12. See the NIHR Funding and Awards website for further award information. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 122 | |
| dc.format.extent | 4269010 | |
| dc.identifier | 285030022 | |
| dc.identifier | 3d8ca015-f66c-45bf-908b-4629eef8e4d3 | |
| dc.identifier | 38512045 | |
| dc.identifier | 85188499565 | |
| dc.identifier.citation | Hutchinson, P J, Edlmann, E, Hanrahan, J G, Bulters, D, Zolnourian, A, Holton, P, Suttner, N, Agyemang, K, Thomson, S, Anderson, I A, Al-Tamimi, Y, Henderson, D, Whitfield, P, Gherle, M, Brennan, P M, Allison, A, Thelin, E P, Tarantino, S, Pantaleo, B, Caldwell, K, Davis-Wilkie, C, Mee, H, Warburton, E A, Barton, G, Chari, A, Marcus, H J, Pyne, S, King, A T, Belli, A, Myint, P K, Wilkinson, I, Santarius, T, Turner, C, Bond, S, Kolias, A G & British Neurosurgical Trainee Research Collaborative and Dex-CSDH Trial Collaborators 2024, 'A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)', Health Technology Assessment, vol. 28, no. 12, pp. 1-122. https://doi.org/10.3310/XWZN4832 | en |
| dc.identifier.doi | 10.3310/XWZN4832 | |
| dc.identifier.iss | 12 | en |
| dc.identifier.issn | 1366-5278 | |
| dc.identifier.other | ORCID: /0000-0003-3852-6158/work/163198771 | |
| dc.identifier.uri | https://hdl.handle.net/2164/23096 | |
| dc.identifier.vol | 28 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Health Technology Assessment | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Adult | en |
| dc.subject | Humans | en |
| dc.subject | Aged | en |
| dc.subject | Hematoma, Subdural, Chronic/drug therapy | en |
| dc.subject | Hospitalization | en |
| dc.subject | Cost-Benefit Analysis | en |
| dc.subject | Double-Blind Method | en |
| dc.subject | Dexamethasone/therapeutic use | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial) | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Hutchinson_etal_HTA_A_Randomised_Double_Blind_VoR.pdf
- Size:
- 4.07 MB
- Format:
- Adobe Portable Document Format
